By Michael Fejtl
When it comes to drug development, the challenge is always to create as much in-vivo relevant data as possible. The more relevant in-vivo data you can gather, the lower the risk of the drug not passing a clinical trial.
But determining confluence is labor-intensive and prone to error, and manual QC for cell-based assays is extremely time-consuming. At the same time, walk-away automation is also difficult to implement. So what’s the answer?
This presentation from SLAS2016 shows how Tecan's new Spark® 20M automates cell imaging, simplifies time-consuming cell assays and provides confidence in what you’re measuring.
If you’re involved in gathering data for drug development, boosting the number of assays you do, simplifying the process and improving accuracy has to be a significant step forward. Watch this video to find out more about what tomorrow could look like for your lab.